[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340534-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340534-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genetic-and-environmental-risks-for-clonal-hematopoiesis-and-cancer-review","Genetic and environmental risks for clonal hematopoiesis and cancer - Review","","Cancer risk and progression are influenced by clonal hematopoiesis (CH), a common age-associated process in which blood or bone marrow contains hematopoietic clones carrying somatic variants linked to malignancies despite no overt cancer. This review explains how somatic variant accumulation, positive selection during cellular stress, and key driver genes shape CH. It links CH to solid and hematopoietic cancers as well as cardiovascular and inflammatory diseases, and discusses how genetic and environmental predisposition inform cancer risk stratification and prevention.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genetic-and-environmental-risks-for-clonal-hematopoiesis-and-cancer-review/340534/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genetic-and-environmental-risks-for-clonal-hematopoiesis-and-cancer-review/340534.png","ImageObject",300,407,{"name":42,"@type":43},"Evangeline","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is clonal hematopoiesis (CH)?","Question",{"text":63,"@type":64},"Clonal hematopoiesis refers to clonal populations of hematopoietic cells with somatic variants associated with myeloid neoplasms found in blood or bone marrow without other evidence of hematopoietic malignancy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which genes are most commonly involved in CH?",{"text":68,"@type":64},"Most CH cases involve a limited set of genes, especially DNMT3A, TET2, and ASXL1. Other frequent genes include PPM1D, JAK2, SF3B1, SRSF2, and TP53.",{"name":70,"@type":61,"acceptedAnswer":71},"How does CH increase cancer and disease risk?",{"text":72,"@type":64},"CH increases risk for solid and hematopoietic malignancies and is also associated with cardiovascular and inflammatory diseases. The review explains that selection and expansion of advantageous clones can eventually contribute to malignant transformation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340534,1790181763,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","REVIEW  \nCancer Focus  \nGenetic and environmental risks for clonal hematopoiesis and cancer  \nStephanie Franco1􀀁 and Lucy A. Godley1,2􀀁  \nSomatic variants accumulate in all organs with age, with a positive selection of clonal populations that provide a fitness advantage during times of heightened cellular stress leading to clonal expansion. Easily measured within the hematopoietic compartment, clonal hematopoiesis (CH) is now recognized as a common process in which hematopoietic clones with somatic variants associated with hematopoietic neoplasms exist within the blood or bone marrow of individuals without evidence of malignancy. Most cases of CH involve a limited number of genes, most commonly DNMT3A, TET2, and ASXL1. CH confers risk for solid and hematopoietic malignancies as well as cardiovascular and numerous inflammatory diseases and offers opportunities for cancer prevention. Here, we explore the genetic and environmental factors that predispose individuals to CH with unique variant signatures and discuss how CH drives cancer progression with the goals of improving individual cancer risk stratification, identifying key intervention opportunities, and understanding how CH impacts therapeutic strategies and outcomes.  \nIntroduction  \nSomatic variants within hematopoietic stem and progenitor cells (HSPCs) occur as a result of random mitotic errors and subsequent DNA damage (Kessler et al., 2022) . The persistence of these errors may result from the failure of DNA damage repair mechanisms, such as double-strand break repair via homologous recombination. These somatic variants accumulate with age and often do not confer major significance to cells, resulting in increased genetic heterogeneity, a form of somatic mosaicism (Quiros and Vassiliou, 2023; Vijg and Dong, 2020) . When somatic variants provide a fitness advantage through enhanced survival and/or proliferation, positive selection and expansion of clonal populations may arise during times of heightened cellular stress (Kessler et al., 2022; Xie et al., 2014) . Selection and expansion ofclonal populations containing somatic variants that possess a survival advantage can lead eventually to malignant transformation (Bolton et al., 2020). Clonal hematopoiesis (CH) refers to the existence of clonal populations of hematopoietic cells containing somatic variants associated with myeloid neoplasms found in the blood or bone marrow of individuals without other evidence of hematopoietic malignancy (Singh and Balasubramanian, 2024) . Less commonly, somatic variants in genes associated with lymphoid malignancies are also involved (Quiros and Vassiliou, 2023) . Drivers of CH can include any  \nsomatic variant, ranging from single nucleotide variants (SNVs) and insertions/deletions to large-scale chromosomal alterations (most commonly, loss of the Y chromosome) (Evans and Walsh, 2023). CH in the absence of a known driver gene variant is likely associated with mosaic chromosome alterations, which also increase in prevalence with age (Evans and Walsh, 2023) . Evans and Walsh provide a more detailed overview of CH associated with chromosome alterations in their review ofCH and somatic mosaicism (Evans and Walsh, 2023) .  \nGenerally, clones with a variant allele frequency (VAF) ≥2% are considered to be of potential significance, with the median VAF being ∼16%(Heuser et al., 2016; Bick et al., 2020) . Clonal hematopoiesis of indeterminant potential (CHIP) refers to CH involving genes associated with hematopoietic malignancy with a VAF of at least 2%(Craven and Ewalt, 2023) . Clonal cytopenia of undetermined significance (CCUS) refers to somatic variants associated with otherwise unexplained cytopenias and is generally considered to be a direct precursor of myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) (Craven and Ewalt, 2023) .  \nA relatively limited number of genes comprise most cases of CH. Studies report that more than 75% of cases of CH are associated with DNMT3A, TET2,","cbCaikHhXRtNADQy","https://ap.wps.com/l/cbCaikHhXRtNADQy","pdf",1266276,11,"English","# Introduction\n## Clonal hematopoiesis definitions and drivers\n## CHIP and CCUS criteria\n## Genes and clinical associations","[{\"question\":\"What is clonal hematopoiesis (CH)?\",\"answer\":\"Clonal hematopoiesis refers to clonal populations of hematopoietic cells with somatic variants associated with myeloid neoplasms found in blood or bone marrow without other evidence of hematopoietic malignancy.\"},{\"question\":\"Which genes are most commonly involved in CH?\",\"answer\":\"Most CH cases involve a limited set of genes, especially DNMT3A, TET2, and ASXL1. Other frequent genes include PPM1D, JAK2, SF3B1, SRSF2, and TP53.\"},{\"question\":\"How does CH increase cancer and disease risk?\",\"answer\":\"CH increases risk for solid and hematopoietic malignancies and is also associated with cardiovascular and inflammatory diseases. The review explains that selection and expansion of advantageous clones can eventually contribute to malignant transformation.\"}]","Genetic and environmental risks for clonal hematopoiesis and cancer - Review | PDF",1790037175,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d2b2ca12166ff57e76ee1252c0afa1a.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e8b282d36a73325bf0683554b8a6916.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7cb06c2d7905379df2836236da38506.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99b4960dfdc29edfca7df5eafd55bb8b.webp",980,1268]